The Promise of Blood-Based Biomarkers in Early Detection and Care of Alzheimer’s Disease
BBMs play a crucial role in combating Alzheimer’s disease and should be prioritized, it is essential for governments and health organizations to finance evaluations in varied demographics, establish coverage policies, and integrate BBMs into existing workflows.